Shares of Celgene (CELG) Ramp as Cowen Upgrades to Buy

Celgene (NASDAQ: CELG) shares are trading up more than 2 percent Tuesday morning following an earlier upgrade from an analyst at Cowen. The firm's investment recommendation was lifted from Neutral to Outperform.

For an analyst ratings summary and ratings history on Celgene click here. For more ratings news on Celgene click here.

Shares of Celgene closed at $61.23 Monday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Piper Sandler Upgrades Tempus AI Inc (TEM) to Overweight, 'On A Train Back To Upside, We're Not Jumping the Gun'
• BofA Securities Upgrades Lloyds Banking Group Plc. (LLOY:LN) (LYG) to Buy
• DA Davidson Upgrades Columbia Banking System (COLB) to Buy